Eagle Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.47M Buy
+44,446
New +$2.59M 0.01% 447
2024
Q2
Sell
-27,606
Closed -$2.2M 567
2024
Q1
$2.2M Sell
27,606
-849
-3% -$64.9K 0.01% 464
2023
Q4
$2.25M Sell
28,455
-4,897
-15% -$349K 0.01% 442
2023
Q3
$2.33M Sell
33,352
-1,868
-5% -$132K 0.01% 422
2023
Q2
$2.43M Buy
35,220
+4,663
+15% +$332K 0.01% 428
2023
Q1
$2.27M Buy
30,557
+5,206
+21% +$437K 0.01% 427
2022
Q4
$2.35M Buy
25,351
+16,580
+189% +$1.6M 0.01% 415
2022
Q3
$836K Sell
8,771
-373
-4% -$36.9K 0.01% 487
2022
Q2
$847K Sell
9,144
-443
-5% -$43.2K 0.01% 495
2022
Q1
$970K Sell
9,587
-322
-3% -$33.8K 0.01% 509
2021
Q4
$1.03M Buy
9,909
+301
+3% +$27.8K ﹤0.01% 524
2021
Q3
$815K Sell
9,608
-228
-2% -$19.1K ﹤0.01% 525
2021
Q2
$820K Buy
9,836
+309
+3% +$25.3K ﹤0.01% 525
2021
Q1
$707K Buy
+9,527
New +$694K ﹤0.01% 523
2020
Q4
Sell
-8,045
Closed -$462K 594
2020
Q3
$462K Sell
8,045
-178
-2% -$11.1K ﹤0.01% 512
2020
Q2
$529K Buy
8,223
+275
+3% +$17.3K ﹤0.01% 516
2020
Q1
$471K Buy
+7,948
New +$531K ﹤0.01% 562
2019
Q2
Sell
-24,975
Closed -$1.35M 643
2019
Q1
$1.35M Sell
24,975
-50,508
-67% -$3.12M 0.01% 533
2018
Q4
$4.95M Buy
75,483
+4,988
+7% +$372K 0.03% 386
2018
Q3
$5.55M Buy
70,495
+433
+0.6% +$31K 0.03% 421
2018
Q2
$4.51M Buy
70,062
+460
+0.7% +$30.3K 0.02% 429
2018
Q1
$4.33M Buy
69,602
+452
+0.7% +$32.4K 0.02% 438
2017
Q4
$5.11M Buy
69,150
+45,389
+191% +$3.3M 0.03% 426
2017
Q3
$1.92M Sell
23,761
-210
-0.9% -$16.6K 0.01% 543
2017
Q2
$1.93M Sell
23,971
-60
-0.2% -$4.74K 0.01% 551
2017
Q1
$1.89M Buy
24,031
+179
+0.8% +$14.3K 0.01% 564
2016
Q4
$1.88M Buy
23,852
+1,038
+5% +$84K 0.01% 558
2016
Q3
$2.03M Sell
22,814
-59,828
-72% -$5.65M 0.01% 553
2016
Q2
$7.91M Sell
82,642
-758
-0.9% -$75.5K 0.05% 347
2016
Q1
$8.65M Sell
83,400
-505
-0.6% -$49.1K 0.06% 335
2015
Q4
$8.2M Sell
83,905
-827
-1% -$81K 0.05% 358
2015
Q3
$8.17M Sell
84,732
-8,068
-9% -$848K 0.06% 350
2015
Q2
$9.73M Sell
92,800
-933
-1% -$95.3K 0.05% 333
2015
Q1
$9.67M Sell
93,733
-1,088
-1% -$110K 0.06% 334
2014
Q4
$9.13M Sell
94,821
-47,928
-34% -$4.22M 0.05% 341
2014
Q3
$11.4M Sell
142,749
-8,538
-6% -$673K 0.07% 308
2014
Q2
$11.4M Sell
151,287
-684
-0.5% -$51.7K 0.06% 320
2014
Q1
$11.4M Sell
151,971
-2,114
-1% -$149K 0.06% 329
2013
Q4
$11M Sell
154,085
-162,535
-51% -$10.4M 0.06% 303
2013
Q3
$18.3M Buy
316,620
+155,039
+96% +$9.24M 0.09% 276
2013
Q2
$9.24M Buy
+161,581
New +$9.36M 0.06% 355

Other funds holding CVS

Eagle Asset Management's CVS Position: Q3 2024 in Review

Eagle Asset Management opened a new position in CVS Health (CVS) in Q3 2024: 44,446 shares worth $2.47M. The stake represents 0.01% of the portfolio and ranks #447 among its holdings. This is a return to the name: Eagle Asset Management previously reported a position in CVS as recently as Q1 2024.

Eagle Asset Management first reported a position in CVS in Q2 2013 and has held it in 41 quarters since. The position peaked at $18.3M in Q3 2013. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Eagle Asset Management held 44,446 shares of CVS Health worth $2.47M as of Q3 2024.
  • CVS Health was a new Eagle Asset Management position in Q3 2024.
  • CVS Health made up 0.01% of Eagle Asset Management's portfolio in Q3 2024, its #447 holding.
  • Eagle Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 41 quarters since.
  • Eagle Asset Management's CVS Health position peaked at $18.3M in Q3 2013.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.